Logo image
IRO Home Research units Researcher Profiles
Sign in
Isoflurane, ketamine-xylazine, and urethane markedly alter breathing even at subtherapeutic doses
Journal article   Open access   Peer reviewed

Isoflurane, ketamine-xylazine, and urethane markedly alter breathing even at subtherapeutic doses

Cory A Massey and George B Richerson
Journal of neurophysiology, Vol.118(4), pp.2389-2401
10/01/2017
DOI: 10.1152/jn.00350.2017
PMCID: PMC5646190
PMID: 28747467
url
https://doi.org/10.1152/jn.00350.2017View
Published (Version of record) Open Access

Abstract

Chemoreceptor Cells - drug effects Isoflurane - pharmacology Male Ketamine - administration & dosage Dose-Response Relationship, Drug Xylazine - administration & dosage Anesthetics, General - pharmacology Respiration - drug effects Xylazine - pharmacology Female Carbon Dioxide - metabolism Serotonergic Neurons - physiology Serotonergic Neurons - drug effects Isoflurane - administration & dosage Mice, Inbred C57BL Cells, Cultured Oxygen Consumption Urethane - administration & dosage Chemoreceptor Cells - physiology Animals Anesthetics, General - administration & dosage Mice Urethane - pharmacology Carbon Dioxide - pharmacology Ketamine - pharmacology

Details

Metrics

Logo image